NCT00240604Unknown3 期
Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids
适应症
相关药物
试验速览
- 阶段
- 3 期
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- plasma glucose concentration
研究概览
简要总结
Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.
详细描述
Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •corticosteroid treatment
排除标准
- •congestive heart failure pedal edema
结局指标
主要结局
plasma glucose concentration
时间窗: 6 months
次要结局
未报告次要终点
研究者
Motti Muszkat
MD
Hadassah Medical Organization
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Pioglitazone in Patients With Mood DisordersMajor Depressive DisorderInsulin ResistanceNCT01559857Stanford University37
Unknown
4 期
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose ToleranceImpaired Glucose ToleranceNCT00733174Denver Research Institute60
已完成
不适用
Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected PatientsInsulin ResistanceNCT00483392University Medical Centre Ljubljana
终止
3 期
Glitazones and Endothelial Function (GATE)Diabetes MellitusNCT00203632University of Calgary40
终止
4 期
Rosiglitazone Versus Placebo in Chronic Stable AnginaMetabolic Syndrome XAngina PectorisNCT00225355University of Glasgow80